Steve Boesing is the Executive Director of Clinical Development at Eli Lilly and Company, specializing in diabetes, obesity, and cardiovascular diseases. They previously served as a Director of Clinical Operations at Xanodyne Pharmaceuticals and held roles in clinical project management and study management at Medpace and INC Research. Steve earned a Bachelor of Science in Biology from Indiana University Bloomington and a Master of Science in Pharmaceutical Drug Development from the University of Cincinnati. Their extensive experience includes leadership positions in clinical trial management and strategic planning across various therapeutic areas.
This person is not in any teams
This person is not in any offices